Gemina, Scarlyte B.
HRN: 23-28-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2023
AMPICILLIN 250MG (VIAL)
07/04/2023
07/10/2023
IVT
150mg
Q6hrs
Pcap C; AGE With Mod DHN
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes